Medical advocacy groups welcomed Johnson & Johnson’s decision not to enforce its patent on a critical tuberculosis medication, allowing its production at much lower prices, after South African authorities opened an investigation into the conglomerate.
South Africa drops probe of J&J after it agrees to lower price of TB drug and withdraws patent
Related Posts
Raccoon roundworm infections reported in Los Angeles County, health officials warn
A rare parasitic infection known as raccoon roundworm has been confirmed in Los Angeles, according to the Los Angeles County Department of Public Health.Two people in the South Bay area…
Vermont caps emergency motel housing for homeless, forcing many to leave this month
BERLIN, Vt. — This fall, hundreds of the most vulnerable people experiencing homelessness in Vermont must leave state-funded motel rooms where they’ve been living as the state winds down its…